Letellier S - Search Results

1

Development of metastases in malignant melanoma is associated with an increase in the plasma L-dopa/L-tyrosine ratio.

Letellier S, Garnier JP, Spy J, Stoitchkov K, Le Bricon T, Baccard M, Revol M, Kerneis Y, Bousquet B. Letellier S, et al. Melanoma Res. 1999 Aug;9(4):389-94. doi: 10.1097/00008390-199908000-00008. Melanoma Res. 1999. PMID: 10504058

2

Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker.

Stoitchkov K, Letellier S, Garnier JP, Bousquet B, Tsankov N, Morel P, Ghanem G, Le Bricon T. Stoitchkov K, et al. Among authors: letellier s. Melanoma Res. 2003 Dec;13(6):587-93. doi: 10.1097/00008390-200312000-00008. Melanoma Res. 2003. PMID: 14646622

3

Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma.

Garnier JP, Letellier S, Cassinat B, Lebbé C, Kerob D, Baccard M, Morel P, Basset-Seguin N, Dubertret L, Bousquet B, Stoitchkov K, Le Bricon T. Garnier JP, et al. Among authors: letellier s. Eur J Cancer. 2007 Mar;43(4):816-21. doi: 10.1016/j.ejca.2006.11.022. Epub 2007 Feb 5. Eur J Cancer. 2007. PMID: 17276671

4

Determination of the L-DOPA/L-tyrosine ratio in human plasma by high-performance liquid chromatography. Usefulness as a marker in metastatic malignant melanoma.

Letellier S, Garnier JP, Spy J, Bousquet B. Letellier S, et al. J Chromatogr B Biomed Sci Appl. 1997 Aug 15;696(1):9-17. doi: 10.1016/s0378-4347(97)00206-5. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9300903

5

Simultaneous analysis of tyrosinase mRNA and markers of tyrosinase activity in the blood of patients with metastatic melanoma.

Le Bricon T, Stoitchkov K, Letellier S, Guibal F, Spy J, Garnier JP, Bousquet B. Le Bricon T, et al. Among authors: letellier s. Clin Chim Acta. 1999 Apr;282(1-2):101-13. doi: 10.1016/s0009-8981(99)00022-4. Clin Chim Acta. 1999. PMID: 10340438

6

Melanoma progression and serum L-dopa/L-tyrosine ratio: a comparison with S100B.

Stoitchkov K, Letellier S, Garnier JP, Bousquet B, Tsankov N, Morel P, Ghanem G, Le Bricon T. Stoitchkov K, et al. Among authors: letellier s. Melanoma Res. 2002 Jun;12(3):255-62. doi: 10.1097/00008390-200206000-00009. Melanoma Res. 2002. PMID: 12140382

7

Evaluation of standard tyrosinase RT-PCR in melanoma patients by the use of the LightCycler system.

Stoitchkov K, Letellier S, Garnier JP, Toneva M, Naumova E, Peytcheva E, Tzankov N, Bousquet B, Morel P, Le Bricon T. Stoitchkov K, et al. Among authors: letellier s. Clin Chim Acta. 2001 Apr;306(1-2):133-8. doi: 10.1016/s0009-8981(01)00400-4. Clin Chim Acta. 2001. PMID: 11282104

8

Hyperglycaemia per se does not affect erythrocyte glucose-6-phosphate dehydrogenase activity in ketosis-prone diabetes.

Choukem SP, Sobngwi E, Garnier JP, Letellier S, Mauvais-Jarvis F, Calvo F, Gautier JF. Choukem SP, et al. Among authors: letellier s. Diabetes Metab. 2015 Sep;41(4):326-330. doi: 10.1016/j.diabet.2014.07.002. Epub 2015 Sep 1. Diabetes Metab. 2015. PMID: 26337344

9

Clinical and biometrological efficacy of a hyaluronic acid-based mesotherapy product: a randomised controlled study.

Baspeyras M, Rouvrais C, Liégard L, Delalleau A, Letellier S, Bacle I, Courrech L, Murat P, Mengeaud V, Schmitt AM. Baspeyras M, et al. Among authors: letellier s. Arch Dermatol Res. 2013 Oct;305(8):673-82. doi: 10.1007/s00403-013-1360-7. Epub 2013 May 29. Arch Dermatol Res. 2013. PMID: 23715889 Free PMC article. Clinical Trial.

10

Usability study on two handheld computers to retrieve drug information.

Letellier S, Leuraud K, Arnaud P, Darmoni SJ. Letellier S, et al. Stud Health Technol Inform. 2005;116:322-7. Stud Health Technol Inform. 2005. PMID: 16160279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters